INHIBRX BIOSCIENCES, INC. Cash Flow Charts

3 years of history · ending 2025-12-31 · SEC EDGAR

Source:10-K · 10-Q

Capital Allocation

How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).

Capital Allocation Waterfall

Buybacks vs Stock-Based Comp

Cash Flow

Cash Flow by Activity

Operating Cash Flow
$-130M
Free Cash Flow
$-130M
Investing Cash Flow
$-28K
Financing Cash Flow
$101M
Capex
$31K
Stock-Based Comp
$11M
D&A
$2M
SBC Allocated Expense
$11M